Spark Therapeutics Stock Price (NASDAQ:ONCE)

Add to My Stocks
$52.41 $0.41 (0.78%) ONCE stock closing price Mar 23, 2017 (Closing)
Spark Therapeutics
23 MAR 2017
amigobulls logo
ONCE hand_up
ONCE vs S&P 500
Closing Price: Mar 23, 2017
$52.41 ( -0.78%)
S&P 500
2346 ( -0.11%)
52 Week Price Range
1 Year Return: 60.64%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Spark Therapeutics Snapshot Video

12 5 2

ONCE Stock Details

Prev Close* : $52.82
Market Cap:
Day Low: $52.17
52 Week Low: $28.38
Open: $52.77
Volume: 178787
Day High: $54.17
52 Week High: $65.99

Latest Stock Market News

Latest Articles

Spark Therapeutics News - From Partners

ONCE Stockcharts

View ONCE PE ratio, PS ratio stocks charts and compare with peers.
ONCE Chart
Note: Compare Spark Therapeutics stock price history with the index and industry peers.

Spark Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

ONCE Industry Peers

Company Price Change (%)
Prothena (PRTA)51.760.03 (0.06%)
Array Biopharma (ARRY)9.220.16 (1.71%)
Dimension Therapeutics (DMTX)1.750 (0%)
Pfizer (PFE)34.290.18 (0.52%)
Baxalta (BXLT)46.020.18 (0.39%)
Sangamo Biosciences (SGMO)4.20.2 (5%)
Regenxbio (RGNX)20.050.4 (1.96%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ALBIREO PHARMA (ALBO)23.783.48 (17.14%)
Trevena (TRVN)3.590.26 (7.81%)
Fate Therapeutics (FATE)4.640.24 (5.45%)
Sangamo BioSciences (SGMO)4.20.2 (5%)
Cara Therapeutics (CARA)16.690.6 (3.73%)
Lion Biotech (LBIO)7.40.25 (3.5%)
Immunomedics (IMMU)6.630.21 (3.27%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 23, 2017
CompanyPriceChange (%)
Ultragenyx Pharma (RARE)71.996.37 (8.13%)
Stemline Therapeutics (STML)8.50.45 (5.03%)
Puma Biotech (PBYI)40.11.45 (3.49%)
MannKind (MNKD)1.950.07 (3.47%)
Emergent Biosolutions (EBS)28.361.01 (3.44%)
Five Prime Therapeutics (FPRX)34.891.16 (3.22%)
Idera Pharma (IDRA)2.420.07 (2.81%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 23, 2017

Spark Therapeutics Inc Stock News - Partner Headlines

Spark Therapeutics Financial Statements

income statement2016201520142013
Net Sales Or Revenues20.18M22.06M0.63M-
Net Income-123.65M-47.12M-24.32M-57.27M
Total Operating Expense-69.37M24.96M57.27M
view Spark Therapeutics Inc income statement
balance sheet201520142013
Total Assets329.77M90.44M4.86M
Total Liabilities39.23M35.24M1.49M
Shareholders Equity290.53M55.2M3.36M
view Spark Therapeutics Inc balance sheet
cash flow statement201520142013
Net Increase (Decrease) In Assets Liabilities-15.83M30.19M1.49M
Net Cash From (Used By) Operating Activities-47.47M10.38M-5.13M
Increase (Decrease) In Prop Plant And Equipment-4.52M-11.69M-
view Spark Therapeutics Inc cashflow statement

Spark Therapeutics Stock Message Board

Spark Therapeutics stock lost 0.28 %, and the last close price as of 22 Mar, 2017 is 52.82 for ONCE stock. Stock price or share price can be used to find the total market value of a company. Spark Therapeutics market cap stands at 1.64B as of 22 Mar, 2017. A value investor must look at the fundamentals of a stock, and perform Spark Therapeutics valuation, even though in the short-term sentiment and current breaking news might affect Spark Therapeutics stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy ONCE stock than sell it, then Spark Therapeutics stock price goes up. Conversely, if more investors wanted to sell ONCE stock than buy it, there would be greater supply than demand, and the stock price would fall. 298662 ONCE shares were traded yesterday, and Spark Therapeutics stock chart shows that the ONCE stock quote hit a day high of 53.63 and day low of 51.73. Spark Therapeutics stock price history, gives the entire historical data for ONCE stock.